Literature DB >> 15658789

T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function.

Winnie H S Goh1, Pek-Lan Khong, Connie S Y Leung, Virginia C N Wong.   

Abstract

The impact of magnetic resonance imaging (MRI)-identified T2-weighted hyperintensities (unidentified bright objects) on the cognitive function of children with neurofibromatosis 1 is controversial. We recruited 32 right-handed children with neurofibromatosis 1 (22 boys, 10 girls) aged between 5 and 16 years (mean age 10.2 years) for magnetic resonance imaging examinations and neuropsychologic evaluation. Statistical analysis was performed to evaluate the significance of the hyperintensities. Twenty-four children had unidentified bright objects, whereas eight children did not. Using the t-test, thalamic lesions were associated with lower intellectual function (P = .031). Left globus pallidus hyperintensities were associated with a lower attention score (P = .04), and right middle cerebellar peduncle hyperintensities were associated with a lower sensorimotor score (P = .05). The size of the thalamic lesions correlated with cognitive function (P < .05). Among the group with unidentified bright objects, there was a significant association between more involved sites on the dominant hemisphere and impaired verbal function (r = -.55; P = .005). Unidentified bright objects in the thalamus, globus pallidus, and middle cerebellar peduncles and the laterality of the lesions had an impact on cognitive function.

Entities:  

Mesh:

Year:  2004        PMID: 15658789     DOI: 10.1177/08830738040190110201

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  16 in total

1.  Brain imaging findings and social/emotional problems in Israeli children with neurofibromatosis type 1.

Authors:  Rony Cohen; Tamar Steinberg; Liora Kornreich; Sharon Aharoni; Ayelet Halevy; Avinoam Shuper
Journal:  Eur J Pediatr       Date:  2014-07-16       Impact factor: 3.183

2.  Clinical Images: Imaging Manifestations of Orbital Neurofibromatosis Type 1.

Authors:  James M Milburn; Carlos R Gimenez; Elizabeth Dutweiler
Journal:  Ochsner J       Date:  2016

3.  T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.

Authors:  Shelley L Hyman; Deepak S Gill; Edwin Arthur Shores; Adam Steinberg; Kathryn N North
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-13       Impact factor: 10.154

4.  Proton MR spectroscopic imaging of basal ganglia and thalamus in neurofibromatosis type 1: correlation with T2 hyperintensities.

Authors:  Charlotte Barbier; Camille Chabernaud; Laurent Barantin; Philippe Bertrand; Catherine Sembely; Dominique Sirinelli; Pierre Castelnau; Jean-Philippe Cottier
Journal:  Neuroradiology       Date:  2010-10-20       Impact factor: 2.804

5.  Visuospatial processing in children with neurofibromatosis type 1.

Authors:  Amy M Clements-Stephens; Sheryl L Rimrodt; Pooja Gaur; Laurie E Cutting
Journal:  Neuropsychologia       Date:  2007-10-02       Impact factor: 3.139

Review 6.  Neurofibromatosis type 1.

Authors:  Kevin P Boyd; Bruce R Korf; Amy Theos
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527

7.  Neurobehavioral profiles in individuals with hyperimmunoglobulin E Syndrome (HIES) and brain white matter hyperintensities.

Authors:  Staci Martin; Pamela Wolters; Nia Billings; Mary Anne Toledo-Tamula; Dima A Hammoud; Pamela Welch; Dirk Darnell; Steven M Holland; Alexandra F Freeman
Journal:  J Clin Immunol       Date:  2013-08-21       Impact factor: 8.317

8.  Evaluation of the basal ganglia in neurofibromatosis type 1.

Authors:  Francesco Nicita; Claudio Di Biasi; Saadi Sollaku; Stefano Cecchini; Vincenzo Salpietro; Angelo Pittalis; Laura Papetti; Fabiana Ursitti; Fiorenza Ulgiati; Anna Maria Zicari; Gian Franco Gualdi; Enrico Properzi; Marzia Duse; Martino Ruggieri; Alberto Spalice
Journal:  Childs Nerv Syst       Date:  2013-07-27       Impact factor: 1.475

9.  Increased prevalence of brain tumors classified as T2 hyperintensities in neurofibromatosis 1.

Authors:  Jennifer L Griffith; Stephanie M Morris; Jasia Mahdi; Manu S Goyal; Tamara Hershey; David H Gutmann
Journal:  Neurol Clin Pract       Date:  2018-08

Review 10.  The Neurofibromatoses.

Authors:  Said Farschtschi; Victor-Felix Mautner; Anna Cecilia Lawson McLean; Alexander Schulz; Reinhard E Friedrich; Steffen K Rosahl
Journal:  Dtsch Arztebl Int       Date:  2020-05-15       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.